Many people with plaque psoriasis can control their symptoms by using topical treatments that are applied to the skin. But some people with moderate or severe plaque psoriasis have symptoms that do ...
Medically reviewed by Leah Ansell, MDMedically reviewed by Leah Ansell, MD Plaque psoriasis is the most common type of psoriasis. Plaques are pink/red, raised, thick, inflamed skin patches covered by ...
Getting a plaque psoriasis diagnosis should be a pretty straightforward process. You see a dermatologist, who looks for the telltale scaly patches on your skin. But diagnosis may not be as direct or ...
The once-daily tablet icotrokinra hydrochloride is approved for adults and adolescents with moderate-to-severe disease.
Johnson & Johnson (NYSE: JNJ) is seeing quick uptake of its oral plaque psoriasis therapy Icotyde in U.S. dermatology ...
Over 8 million adults in the U.S. experience plaque psoriasis — a chronic autoimmune disease that causes painful, raised, scaly spots on the skin. People with plaque psoriasis often employ a host of ...
Apremilast is effective for the treatment of patients with plaque psoriasis who have limited skin involvement, including in high-impact areas.
The skin condition psoriasis affects about 8 million people in the U.S. – or around 2% to 3% of the population. And the vast majority of cases – an estimated 80% to 90% – involve one particular form ...
Dr Mark Lebwohl explains disease burden for patients with plaque psoriasis and discusses the common comorbidities clinicians see. Ryan Haumschild, PharmD, MS, MBA: I'm interested, Dr Lebwohl, on ...
The IL-23 blocker guselkumab significantly reduced disease severity compared with placebo in children and adolescents with ...
A federal judge blocked CMS from requiring medically frail Medicaid enrollees to prove their illness limits work, but work requirements and documentation rules remain in place. HHS Drops Expired 2025 ...
Developing psoriasis didn’t exactly help with that internal dialogue. I began noticing symptoms when I was around 20, back in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results